Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4MOT

Structure of Streptococcus pneumonia pare in complex with AZ13072886

Summary for 4MOT
Entry DOI10.2210/pdb4mot/pdb
Related4EM7 4EMV 4MB9 4MBC
DescriptorTopoisomerase IV subunit B, 1-[4-(3-methylbutyl)-5-oxo-6-(pyridin-3-yl)-4,5-dihydro[1,3]thiazolo[5,4-b]pyridin-2-yl]-3-prop-2-en-1-ylurea (3 entities in total)
Functional Keywordsatp binding, structure-based drug design, antimicrobial, virtual screen, isomerase-isomerase inhibitor complex, isomerase/isomerase inhibitor
Biological sourceStreptococcus pneumoniae
Total number of polymer chains1
Total formula weight24998.22
Authors
Ogg, D.,Boriack-Sjodin, P.A. (deposition date: 2013-09-12, release date: 2013-11-20, Last modification date: 2024-02-28)
Primary citationKale, R.R.,Kale, M.G.,Waterson, D.,Raichurkar, A.,Hameed, S.P.,Manjunatha, M.R.,Kishore Reddy, B.K.,Malolanarasimhan, K.,Shinde, V.,Koushik, K.,Jena, L.K.,Menasinakai, S.,Humnabadkar, V.,Madhavapeddi, P.,Basavarajappa, H.,Sharma, S.,Nandishaiah, R.,Mahesh Kumar, K.N.,Ganguly, S.,Ahuja, V.,Gaonkar, S.,Naveen Kumar, C.N.,Ogg, D.,Boriack-Sjodin, P.A.,Sambandamurthy, V.K.,de Sousa, S.M.,Ghorpade, S.R.
Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy.
Bioorg.Med.Chem.Lett., 24:870-879, 2014
Cited by
PubMed Abstract: Scaffold hopping from the thiazolopyridine ureas led to thiazolopyridone ureas with potent antitubercular activity acting through inhibition of DNA GyrB ATPase activity. Structural diversity was introduced, by extension of substituents from the thiazolopyridone N-4 position, to access hydrophobic interactions in the ribose pocket of the ATP binding region of GyrB. Further optimization of hydrogen bond interactions with arginines in site-2 of GyrB active site pocket led to potent inhibition of the enzyme (IC50 2 nM) along with potent cellular activity (MIC=0.1 μM) against Mycobacterium tuberculosis (Mtb). Efficacy was demonstrated in an acute mouse model of tuberculosis on oral administration.
PubMed: 24405701
DOI: 10.1016/j.bmcl.2013.12.080
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.75 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon